Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Formula to raise financing for leukemia vaccine Phase II trials
The leukemia vaccine will be used during first remission for acute myeloid leukemia and other aggressive cancers. Earlier Phase I study showed a survival benefit of 54 months
The leukemia vaccine will be used during first remission for acute myeloid leukemia and other aggressive cancers. Earlier Phase I study showed a survival benefit of 54 months
Lixisenatide QD had a greater post-prandial glucose lowering (PPG) effect than liraglutide QD in patients with Type 2 diabetes (-129% versus -41%, respectively). It is accompanied by significant
According to the company, Coliminate comprises a blend of herbs which are believed to soothe, regulate and balance colon health. Coliminate helps in the treatment of irritable bowel
According to the company, the product reduces the amount of sugar in the blood stream by preventing the absorption of glucose in the intestine, so that the body
Trimel intends to use the Dunwin facility to manufacture clinical supplies for its CompleoTRT and TBS-2 (Anorgasmia) products. The company intends to use Dunwin facility to even the
IBM SPSS Data Collection Web Interviews which forms as part of a data collection system has been deployed by the clinic, techworld.com.au reported. This data collection system is
Tranexamic Acid Injection, 100 mg/mL are packaged in 1,000 mg/10 mL Single-dose Vials. This product is the generic version of Pharmacia & Upjohn’s Cyklokapron Injection. Tranexamic Acid Injection
The collaboration is intended to evaluate the utility of Daclatasvir (BMS-790052), Bristol-Myers Squibb’s investigational NS5A replication complex inhibitor, along with Tibotec Pharmaceuticals’ NS3 protease inhibitor, TMC435, for the
Teva’s Atorvastatin Calcium Tablets are the generic equivalent forms of Pfizer’s Lipitor. During Ranbaxy’s 180-day first-to-file exclusivity period, a portion of the profits from its sales of Atorvastatin
The multi-center, open-label Phase 2 Study 010 is designed to assess the safety and pharmacokinetic (PK) effects of four increasing oral doses of AT2220 co-administered with ERT versus